"Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address. Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues."

During the past decade, Metabolic Research Institute, Inc. conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 32 clinical trials were completed, i.e. on average, 86.5% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 18 clinical trials were completed. i.e. 78.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metabolic Research Institute, Inc." #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "AstraZeneca" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metabolic Research Institute, Inc." #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Integrium" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Barc NV" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Metabolic Research Institute, Inc." are "Diabetes Mellitus, Type 2" (7 trials), "Type 2 Diabetes Mellitus" (7 trials), "Obesity" (6 trials), "Overweight" (5 trials) and "Type 2 Diabetes" (5 trials). Many other conditions were trialed in "Metabolic Research Institute, Inc." in a lesser frequency.

Most popular intervention types in "Metabolic Research Institute, Inc." are "Drug" (55 trials), "Device" (8 trials), "Other" (6 trials), "Biological" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Tirzepatide" (5 trials), "AC2993" (4 trials), "Insulin Degludec" (3 trials) and "Darusentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metabolic Research Institute, Inc." are 66 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Metabolic Research Institute, Inc.". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Metabolic Research Institute, Inc., 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Metabolic Research Institute, Inc., 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".